MedPath

Impact of OAB Symptoms on Quality of Life in Croatia

Conditions
Overactive Bladder
Interventions
Other: Overactive Bladder-Validated 8-question Screener (OAB-V8)
Registration Number
NCT04865328
Lead Sponsor
University of Zagreb
Brief Summary

Overactive bladder (OAB) has a negative impact on the daily activities of affected individuals. OAB affects an estimated 12-17% of adults and has a similar reported prevalence in men and women. It has the potential to impair multiple domains of quality of life, including restriction of social and work life, while also resulting in higher healthcare resource use and costs.

The primary objective of the present study was to evaluate, in a Croatian population reporting symptoms of OAB, the effect on work productivity and treatment behaviors (treatment seeking, receiving treatment, treatment dissatisfaction and treatment discontinuation).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
250
Inclusion Criteria
  • consenting adult patients who had an OAB diagnosis by their healthcare practitioner and were about to start mirabegron treatment as part of routine clinical practice were eligible for enrollment.
Exclusion Criteria
  • mixed incontinence where stress incontinence was the predominant symptom (as determined by the investigator)
  • severe uncontrolled hypertension (i.e. systolic blood pressure ≥180 mm Hg and/or diastolic blood pressure ≥110 mm Hg)
  • anxiety and/or depression
  • pregnancy
  • women who reported having either a current or previous (within one month) urinary tract infection

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
OAB groupOveractive Bladder-Validated 8-question Screener (OAB-V8)Group with diagnosed overactive bladder.
Primary Outcome Measures
NameTimeMethod
OAB-V8 score > 8At the point of recruitment

The primary study objective is to investigate the impact of individual LUTS on specific outcomes in the population reporting OAB symptoms. OAB-V8 score.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinical Hospital Centre Zagreb, Croatia

🇭🇷

Zagreb, Croatia

© Copyright 2025. All Rights Reserved by MedPath